PATH · UiPath Inc
Price
Snapshot
50 fields · last close| Market Cap | $6.84B |
| P/E | 18.89 |
| Float | 408.9M |
| Beta | 1.06 |
| Volatility | 26.4% |
| Exchange | NYSE |
| Sector | Technology |
| Cap tier | Mid cap |
| Macro sensitivity | Moderate |
| Clavix score | 49.7 |
| Price | 13.12 |
| Change | +0.00% |
| Prev Close | 13.12 |
| Open | 13.41 |
| Day Low | 13.02 |
| Day High | 13.42 |
| Avg Vol | 43 |
| Avg $ Vol | $563.6M |
| 52W High | 19.84 |
| 52W Low | 9.20 |
| 52W Pos | 36.8% |
| From High | −33.87% |
| From Low | +42.61% |
| Max DD 1Y | −51.37% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | −2.38% |
| SMA 50 | −10.09% |
| SMA 200 | +3.48% |
| RSI (14) | 43.3 |
| Vol 30D | 75.1% |
| Vol 90D | 67.0% |
| 1Y Range | 9–20 |
| Daily bars | 526 |
| Perf Week | +5.30% |
| Perf Month | −27.07% |
| Perf Quarter | +10.90% |
| Perf Half Y | +16.73% |
| Perf Year | +1.00% |
| Perf YTD | −17.38% |
| Prev Day | +0.00% |
| Clavix | C- |
| Debt / Eq | 0.00 |
| Curr Ratio | 2.48 |
| Int Cover | -42.6× |
| FCF Margin | 21.9% |
| Rev Growth | +12.7% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 55 / 100 |
Clavix risk grade
regraded every trading dayPATH grades C-, 49.7 of 100. Steadiest on Sector Resilience (68), most exposed on News Sentiment (23, weak). 0 of the 4 weighted dimensions sit above the Technology median. Ranks 55 of 100 in Technology by Clavix score.
How rough the ride is
| PATH | Technology median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.06 | 1.26 |
| Volatilityannualized | 26.4% | 32.0% |
| Max drawdown, past yearworst peak-to-trough fall | −51.4% | — |
| Typical daily movemedian absolute daily change | 2.08% | — |
| Days beyond ±3%of the last 252 sessions | 98 (39%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| PATH | Technology median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.06 | 1.26 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 40% of 102 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Technology names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| PATH | |
|---|---|
| 1 week | +5.3% |
| 1 month | −27.1% |
| Year to date | −17.4% |
| 1 year | +1.0% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| PATH | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 17 Sep |
| Average score0 most bearish, 100 most bullish | 63 |
| Bullish · bearisharticles above 60 · below 40 | 23 · 6 |
| Directionarticles whose tone is improving vs worsening | 23 ↑ 6 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 100 Technology names Clavix covers; the tick is the sector median.
Growth
| PATH | |
|---|---|
| Revenue growthyear over year | +12.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Technology median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openUiPath joined a National Committee for Quality Assurance (NCQA) program focused on using artificial intelligence in healthcare prior authorization, the process where insurers approve treatments before they happen. UiPath shares rose 2.88% to $13.21 following the announcement, and the company plans to attend NCQA's Health Innovation Summit from October 4 through October 7.
An analyst reiterates a Buy rating on UiPath, citing the company's expanded agent-building and orchestration features and raised FY2027 guidance, with a bull-case long-term price target of $24.60 per share. The analyst frames the recent share price drop as a buying opportunity.
UiPath joined the National Committee for Quality Assurance's (NCQA) AI Learning Collaborative for Prior Authorization as a case-study contributor, helping health insurers move from experimenting with it to putting it into use under formal rules.
The article points to the company's raised fiscal 2026 revenue outlook of $1.789 to $1.794 billion (about 11% year-over-year growth), a 22% pro forma operating margin, 109% net revenue retention, and accelerating large-customer growth tied to AI demand.
Two healthcare companies speaking at UiPath's FUSION 2026 event said that the 85% accuracy level most enterprise AI targets is too low for healthcare, where errors cause denied claims, underpaid providers, and compliance problems. Their fix is to design workflows around the AI's known weaknesses rather than ignore them.
Nearest peers by size
Technology| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| CIFR | Cipher Digital Inc | F | $6.52B | — | 3.46 | Compare |
| TTAN | ServiceTitan Inc | C- | $6.47B | — | 1.42 | Compare |
| NTSK | Netskope Inc | D+ | $7.25B | — | 2.47 | Compare |
| DBX | Dropbox Inc | B | $7.37B | 16.65 | 0.60 | Compare |
| RIOT | Riot Platforms Inc | D- | $7.40B | — | 3.95 | Compare |
| APLD | Applied Digital Corp | F | $7.59B | — | 5.55 | Compare |
| BB | BlackBerry Ltd | D+ | $7.65B | 89.75 | 1.22 | Compare |
| PCOR | Procore Technologies Inc | B- | $7.74B | — | 0.79 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.